| [1] |
Morita K, Fuwa N, Suzuki Y, et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I:retrospective analysis of 149 patients. Radiother Oncol, 1997, 42(1):31-36.
|
| [2] |
Etiz D, Marks LB, Zhou SM, et al. Influnce of tumor volume on survival in patients irradiation for non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 2002, 53(4):835-846.
|
| [3] |
Nagata Y, Negom Y, Aoki T, et al. Clinical outcomes of 3-D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys, 2002, 52(5):1041-1046.
|
| [4] |
Abratt RP. Modeling tumor and treated lung tumor volume influence in the irradiation of non-small cell lung cancer patients. Int J Radiat Oncol Biol Phys, 2001, 49(2):481-485.
|
| [5] |
Chung PC, Miackillop WJ, Dixon P, et al. Involved-field radiotherapy alone for early stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 2000, 48(3):703-711.
|
| [6] |
Bradley, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311:a phase I-II dose-esclation study using three-dimentional conformal radiotherapy in patients with inoperable non-smallcell lung carcinoma. Int J Radiat Oncol Biol Phys, 2005, 61(2):318-328.
|
| [7] |
Wu KL, Jiang GL, Liao Y, et al. Three-dimensional conformal radiation therapy for non-small cell lung cancer:A phase Ⅰ/Ⅱ dose escalation clinical trial. Int J Radiat Oncol Biol Phys, 2003, 57(5):1336-1344.
|
| [8] |
Schwegler N, Vrh N, Kern T, et al. Local efficiency of percutaneous radiotherapy in lung cancer. Analysis of 215 repeated bronchoscopies in relation to applied radiation dosage. Strahlenther Oncol,1996, 172(1):81-90.
|
| [9] |
Rosenman JG, Halle JS, Socinski MA, et al. High-dose conformal radiotherapy for treatment of stage ⅢA/ⅢB non-small cell lung cancer:Technical issues and results of a phase Ⅰ/Ⅱ trial. Int J Radiat Oncol Biol Phys, 2002, 54(2):348-356.
|
| [10] |
Lee SW, Choi EK, Lee J, et al. Phase Ⅱ study of three-dimensional conformal radiotherapy and concurrent mitomycin-c vinblastine andcisplatin chemotherapy for stage Ⅲ locally advanced,unresectablen on-small cell lung cancer. Int J Radiat Oncol Biol Phys, 2003, 56(4):996-1004.
|